Pluri (PLUR) Appoints Lorne Abony to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St rises with earnings in focus; PayPal jumps on takeover bid report
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices rise as hostilities worsen in the Middle East
- ASML capacity upgrade soothes AI chip bottleneck fears
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Kosovo bans Serb minister over ethnic cleansing remarks
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of Directors
July 13, 2023 2:01 AM EDTHAIFA, Israel, July 13, 2023 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (Pluri or the Company), a leading biotech company that transforms cells into solutions that promote wellbeing and sustainability, today announced the appointment of Lorne Abony to the Companys Board of Directors, effective as of July 11, 2023.Â
Abony is a successful entrepreneur who has decades of experience building and scaling multi-billion-dollar global businesses both public and private companies across multiple industries. He is a globally recognized leader who has invested, directly or indirectly, in more than 20 cellular... More
